Prescription Drug Diversion P - Peppin
94,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

Prescription Drug Diversion and Pain provides an interdisciplinary overview of medications used to treat chronic pain, specifically the benefits and risks that are posed by long-term opioids use. This book offers a single, comprehensive source for understanding the specialzied field of the opioid crisis and is a must-read for healthcare professionals, caregivers, policy makers, regulatory officials, law enforcement, and those in the pharmaceutical industryseeking to address the current and future opioid crisis.

Andere Kunden interessierten sich auch für
Produktbeschreibung
Prescription Drug Diversion and Pain provides an interdisciplinary overview of medications used to treat chronic pain, specifically the benefits and risks that are posed by long-term opioids use. This book offers a single, comprehensive source for understanding the specialzied field of the opioid crisis and is a must-read for healthcare professionals, caregivers, policy makers, regulatory officials, law enforcement, and those in the pharmaceutical industryseeking to address the current and future opioid crisis.
Autorenporträt
Dr. Peppin is board certified in Internal Medicine and pain medicine and is a certified EPEC trainer. Elected Fellow of the American College of Physicians, Kentucky Colonel in 2009 and PainWeek 2011 Clinician of the Year he has been active in the pain, palliative medicine, bioethics and internal medicine fields for over 20 years. Has published over 65 articles in the fields of pain management, palliative care and bioethics and edited books and given numerous lectures, papers and posters at conferences nationally and internationally. Dr. Peppin has been a reviewer for the Cochrane PaPaS group. Additionally he has been on editorial boards and is a reviewer for multiple journals. He currently has an active health care consulting business. Dr. Coleman's career began with fighting the French Connection, first in New York City, and then as Narcotics Attaché assigned to the American Embassy in Paris, France. His assignments carried him throughout the U.S. and around the world. He was appointed Assistant Administrator of the DEA in charge of operations, including the Office of Diversion Control. After retiring, Dr. Coleman founded the Prescription Drug Research Center LLC to assist companies in developing Abuse-Deterrent Drugs. Dr. Coleman was elected President of DrugWatch International, Inc., a global non-profit group dedicated to fighting drug abuse through education and prevention. Dr. Dineen is the director of the health law program at Creighton University School of Law. Before earning her JD and PhD (health care ethics), she practiced nursing in several practice areas, including working with many patients with chronic persistant pain. Her law practice included representing individual and institutional health care clients in regulatory and licensure matters. Dr. Dineen's current research focuses on the decision making in health policy and regulation and the impact on people with highly stigmatized conditions, such as high-impact chronic pain and addiction. Mr. Ruggles is a licensed attorney and current Ph.D. student. While earning his J.D. from Saint Louis University, he served the indigent population within the Archdiocese of Saint Louis through his work with Catholic Legal Assistance Ministry. Following law school and admittance to the Missouri Bar, he finished coursework towards a Ph.D. in health care ethics. His areas of interest include addiction, end of life issues, and the various other intersections of law and bioethics.